Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
50.72%
Operating Margin
23.62%
Net Margin
18.19%
Efficiency Metrics
Revenue per Expense Ratio
1.31
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
29.42%
Income Tax Rate
0.50%
EPS
0.9200000000
Balance Sheet Analysis
Current Ratio
0.89
Cash Ratio
0.40
Working Capital
$-4.44B
Debt to Equity
0.04
Debt to Assets
2.59%
Equity Ratio
58.44%
Cash Flow Analysis
Operating Cash Flow Ratio
30.99%
Free Cash Flow Ratio
23.46%
CapEx to Revenue
7.53%
Dividends Paid
$11.92B
Stock Buybacks
$118.99M
Total Shareholder Returns
$12.04B
Cash Position Change
7.59%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
0.04%
Net Income
0.30%
EPS
0.00%
Operating Income
6.46%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-2.22%
Operating Cash Flow
19.71%
Free Cash Flow
32.59%
Balance Sheet Health
Assets
-3.85%
Debt
-8.94%
Book Value per Share
-4.41%
Inventory
-25.57%
Shareholder Returns
Dividends per Share
-3.21%
Shares Outstanding
0.62%
Long Term Trends
3Y Revenue/Share
35.67%
5Y Revenue/Share
57.53%
3Y Dividend/Share
72.88%
5Y Dividend/Share
34.23%